Lupin launches Molnulup for COVID-19 treatment

Molnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34jgjmi
via IFTTT